Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 415
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT00193882 | Advanced Oesophageal Cancer Study to Compare Quality of Life and Palliation of Dysphagia. | ||
| NCT02414022 | Economic Analysis of Alliance A041202 CLL Study | ||
| NCT00040183 | OSI-774 (Tarceva) Plus Gemcitabine in Patients With Locally Advanced, Unresectable or Metastatic Pancreatic Cancer. | ||
| NCT03233711 | Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer | ||
| NCT02125006 | The Effect of an Inter-Disciplinary Program, Including MBSR, in Breast Cancer Survivors With Chronic Neuropathic Pain | ||
| NCT06323707 | The IMPACT Implementation-Effectiveness Trial | ||
| NCT01506687 | Increasing Colorectal Cancer Screening Uptake With a Patient Navigator | ||
| NCT03055871 | Parents and Children Active Together Study | ||
| NCT05452824 | Participating in Tai Chi to Reduce Anxiety and Keep up Physical Function | ||
| NCT02870920 | Durvalumab and Tremelimumab and Best Supportive Care vs Best Supportive Care in Patients With Advanced Colorectal Cancer | ||
| NCT01152788 | Phase II Study of Interleukin-21 (rIL-21) vs Dacarbazine (DTIC) in Patients With Metastatic or Recurrent Melanoma | ||
| NCT04176848 | CFI-400945 and Durvalumab in Patients With Advanced Triple Negative Breast Cancer | ||
| NCT00343408 | AZD2171 and Standard Combination Chemotherapy in Advanced Non-Small Cell Lung Cancer or Colorectal Cancer | ||
| NCT03917082 | Limited Adjuvant Endocrine Therapy for Low Risk Breast Cancer | ||
| NCT04746859 | Evaluation of the Effectiveness and Implementation of the BETTER Women Peer Health Coaching Program | ||
| NCT00026338 | Gemcitabine With/Out Erlotinib in Unresectable Locally Advanced/Metastatic Pancreatic Cancer | ||
| NCT01068587 | MET/VEGFR2 Inhibitor GSK1363089 and Erlotinib Hydrochloride or Erlotinib Hydrochloride Alone in Locally Advanced or Metastatic NSCLC That Has Not Responded to Previous Chemotherapy | ||
| NCT04685616 | Brentuximab Vedotin in Early Stage Hodgkin Lymphoma | ||
| NCT00002583 | Vinorelbine + Cisplatin or No Further Therapy in Non-small Cell Lung Cancer That Has Been Surgically Removed | ||
| NCT03585634 | The Dads in Gear Program: An Innovative Men-centered Approach to Smoking Cessation | ||
| NCT01515787 | PROSPECT: Chemotherapy Alone or Chemotherapy Plus Radiation Therapy in Treating Patients With Locally Advanced Rectal Cancer Undergoing Surgery | ||
| NCT02225015 | Cancer Prevention in Women With a BRCA Mutation | ||
| NCT03480776 | ASA in Prevention of Ovarian Cancer (STICs and STONEs) | ||
| NCT00770185 | Ridaforolimus in Treating Patients With Recurrent Metastatic and/or Locally Advanced Endometrial Cancer | ||
| NCT03748550 | Exercise to Prevent AnthraCycline-based Cardio-Toxicity Study 2.0 (EXACT2) | ||
| NCT00640471 | Cetuximab With or Without Brivanib in Treating Patients With K-Ras Wild Type Tumours and Metastatic Colorectal Cancer | ||
| NCT00245154 | Paclitaxel + Carboplatin With/Out Cediranib Maleate in Stage III or Stage IV Non-Small Cell Lung Cancer | ||
| NCT00053794 | Perifosine in Treating Patients With Metastatic or Locally Advanced Soft Tissue Sarcoma | ||
| NCT03461952 | Nivolumab Ipilimumab in Patients With hyperMutated Cancers Detected in Blood (NIMBLe) | ||
| NCT05371808 | Economic Analysis of Early vs Delayed Therapy in Newly Diagnosed Asymptomatic High-Risk Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: | ||
| NCT01145989 | A Study of AT9283 in Patients With Relapsed or Refractory Multiple Myeloma | ||
| NCT00093457 | Sorafenib in Treating Patients With Metastatic or Recurrent Prostate Cancer | ||
| NCT00490139 | ALTTO (Adjuvant Lapatinib And/Or Trastuzumab Treatment Optimisation) Study; BIG 2-06/N063D | ||
| NCT00002866 | Docetaxel and Epirubicin With and Without G-CSF in Treating Women With Metastatic Breast Cancer | ||
| NCT03938987 | Anti-CD19, Dual Co-stimulatory (4-1BB, CD3ζ) Chimeric Antigen Receptor T-cells in Patients With Relapsed/Refractory Aggressive Lymphoma or Acute Lymphoblastic Leukemia (ALL) | ||
| NCT03259035 | NEO: Neoadjuvant Chemotherapy, Excision and Observation for Early Rectal Cancer | ||
| NCT02905318 | Palbociclib in Patients With Metastatic Castration-Resistant Prostate Cancer | ||
| NCT03271892 | Deciding on Active Surveillance or Surgery for Primary Management of Low Risk Papillary Thyroid Cancer | ||
| NCT01708993 | Reolysin in Previously Treated Advanced/Metastatic, Non Small Cell Lung Cancer Receiving Standard Salvage Therapy | ||
| NCT00006036 | Liposomal Lurtotecan Plus Cisplatin in Treating Patients With Advanced or Metastatic Solid Tumors | ||
| NCT01972984 | Feasibility Study of Presurgical Hormone Therapy (Anastrozole) in Breast Cancer Patients | ||
| NCT00003684 | Theophylline in Treating Cancer Patients With Shortness of Breath | ||
| NCT02512965 | Study Comparing Stereotactic Body Radiotherapy vs Conventional Palliative Radiotherapy (CRT) for Spinal Metastases | ||
| NCT04650581 | Fulvestrant and Ipatasertib for Advanced HER-2 Negative and Estrogen Receptor Positive (ER+) Breast Cancer Following Progression on First Line CDK 4/6 Inhibitor and Aromatase Inhibitor | ||
| NCT03258554 | Radiation Therapy With Durvalumab or Cetuximab in Treating Patients With Locoregionally Advanced Head and Neck Cancer Who Cannot Take Cisplatin | ||
| NCT02003222 | Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia | ||
| NCT05255653 | Refining Adjuvant Treatment IN Endometrial Cancer Based On Molecular Features | ||
| NCT04771975 | Connecting Breast Cancer Survivors for Exercise | ||
| NCT00377052 | Bortezomib and Gemcitabine in Treating Patients With Relapsed Mantle Cell Lymphoma | ||
| NCT01622543 | Reolysin in Combination With FOLFOX6 and Bevacizumab or FOLFOX6 and Bevacizumab Alone in Metastatic Colorectal Cancer |
